Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Revance Therapeutics (RVNC)
Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 482,093
  • Shares Outstanding, K 87,813
  • Annual Sales, $ 132,570 K
  • Annual Income, $ -356,420 K
  • 60-Month Beta 0.99
  • Price/Sales 2.13
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade RVNC with:

Options Overview Details

View History
  • Implied Volatility 109.55% ( -5.42%)
  • Historical Volatility 92.11%
  • IV Percentile 86%
  • IV Rank 63.98%
  • IV High 146.55% on 01/03/24
  • IV Low 43.83% on 05/12/23
  • Put/Call Vol Ratio 0.19
  • Today's Volume 415
  • Volume Avg (30-Day) 623
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 25,053
  • Open Int (30-Day) 23,663

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.78
  • Number of Estimates 2
  • High Estimate -0.75
  • Low Estimate -0.81
  • Prior Year -1.82
  • Growth Rate Est. (year over year) +57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.00 +9.80%
on 02/01/24
6.41 -14.35%
on 01/24/24
-0.54 (-8.96%)
since 01/23/24
3-Month
5.00 +9.80%
on 02/01/24
9.74 -43.66%
on 01/02/24
-1.80 (-24.69%)
since 11/22/23
52-Week
5.00 +9.80%
on 02/01/24
37.98 -85.55%
on 05/09/23
-28.56 (-83.88%)
since 02/23/23

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revance Therapeutics, Inc. - RVNC

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC). Such...

RVNC : 5.49 (+3.39%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revance Therapeutics, Inc. - RVNC

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC). Such...

RVNC : 5.49 (+3.39%)
Revance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Tops Revenue Estimates

Revance Therapeutics, Inc. (RVNC) delivered earnings and revenue surprises of 1.33% and 8.53%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

RVNC : 5.49 (+3.39%)
TMBR : 0.3426 (+0.74%)
Top 4 Stocks Set to Beat on Earnings Today After Market Closes

We have narrowed our search to four stocks that are set to report earnings results today after market closes. These are: WYNN, CELH, RVNC and IAC.

WYNN : 104.16 (+1.70%)
RVNC : 5.49 (+3.39%)
IAC : 56.69 (-1.70%)
CELH : 64.05 (-0.12%)
Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Misses Revenue Estimates

Omega Therapeutics, Inc. (OMGA) delivered earnings and revenue surprises of 21.88% and 31.20%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

OMGA : 3.69 (+2.93%)
RVNC : 5.49 (+3.39%)
Revance to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023

Revance Therapeutics, Inc. (RVNC), today announced that the company will release first quarter 2023 financial results on Tuesday, May 9, 2023, after the close of market. Revance will host a corresponding...

RVNC : 5.49 (+3.39%)
Revance to Participate in the Needham 22nd Annual Healthcare Conference

Revance Therapeutics, Inc. (Nasdaq: RVNC), today announced that the company will participate in the 22 nd Annual Needham Virtual Healthcare Conference, taking place April 17 – 20, 2023. Chief Financial...

RVNC : 5.49 (+3.39%)
Revance Publishes its 2022 Environmental, Social, and Governance (ESG) Report

Revance Therapeutics, Inc. (RVNC), today announced the release of its 2022 ESG Report, detailing the company’s progress towards its ESG priorities of innovation and access, workplace culture and strong...

RVNC : 5.49 (+3.39%)
Intra-Cellular (ITCI) Surges 16.4%: Is This an Indication of Further Gains?

Intra-Cellular (ITCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

ITCI : 70.16 (-2.46%)
RVNC : 5.49 (+3.39%)
Revance to Participate in Upcoming Investor Conferences

Revance Therapeutics, Inc. (RVNC), today announced that the company will participate in the following investor conferences.

RVNC : 5.49 (+3.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including dermatology and neurology. Revance's science is based upon a proprietary TransMTS' peptide technology, which when combined...

See More

Key Turning Points

3rd Resistance Point 6.05
2nd Resistance Point 5.84
1st Resistance Point 5.66
Last Price 5.49
1st Support Level 5.27
2nd Support Level 5.06
3rd Support Level 4.88

See More

52-Week High 37.98
Fibonacci 61.8% 25.38
Fibonacci 50% 21.49
Fibonacci 38.2% 17.60
Last Price 5.49
52-Week Low 5.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar